AMGN: Amgen Inc. Stock Live Price Graph
About the company
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $2.52 | $2.52 | 3.00% | - |
What Is AMGN? Live AMGN Prices and Analysis
AMGN, or Amgen Inc., is a leading biotechnology company that develops and manufactures human therapeutics. Established in 1980, Amgen has become one of the largest independent biotechnology companies globally, focusing on innovative medicines that address serious illnesses. Investors closely follow AMGN due to its significant role in the healthcare sector and its impact on biotechnology stock performance.
As a prominent player in the biotechnology industry, AMGN's performance is crucial not only for its shareholders but also for understanding trends in the broader healthcare market. The company's advancements in drug development and the introduction of new therapies can drive stock prices, making it an essential asset for investors seeking exposure to biotech.
Market Context for AMGN
The biotechnology sector is characterized by rapid growth and innovation, but it also faces significant regulatory scrutiny and market volatility. AMGN trades primarily on the NASDAQ, with pricing in U.S. dollars. The stock can experience fluctuations based on various factors, including clinical trial results, regulatory approvals, and overall market sentiment towards healthcare stocks.
Why Do AMGN Prices Rise or Fall?
The price of AMGN shares can be influenced by several factors that investors should consider when analyzing the stock.
- Clinical trial outcomes: Positive results can lead to stock price increases, while negative outcomes may cause declines.
- Regulatory approvals: Successful FDA approvals for new drugs can boost investor confidence and stock prices.
- Market competition: The introduction of competing therapies can impact AMGN's market share and profitability.
- Earnings reports: Quarterly earnings that exceed or fall short of expectations can lead to significant price movements.
- Mergers and acquisitions: News of potential mergers or acquisitions can create volatility in share prices.
- Market trends: Overall trends in the biotechnology and healthcare sectors can influence AMGN's stock performance.
- Investor sentiment: Changes in investor perception regarding the biotechnology industry can lead to price fluctuations.
- Economic indicators: Broader economic conditions can impact healthcare spending and, consequently, AMGN's revenues.
Understanding these factors can help investors make informed decisions regarding AMGN, allowing them to capitalize on potential price movements.
Why Is Live AMGN Price Tracking Important?
Tracking live AMGN prices is crucial for investors who wish to stay informed about market conditions and make timely trading decisions. By monitoring real-time price movements, investors can better understand market trends and capitalize on buying or selling opportunities.
- Identify trends: Live price tracking helps investors spot trends that may indicate future price movements.
- Set entry and exit points: Investors can use live pricing to determine optimal times to buy or sell shares.
- React quickly: Real-time data allows investors to respond promptly to market changes or news events.
- Analyze volatility: Tracking price fluctuations can help investors assess the stock's risk and volatility.
- Support technical analysis: Live prices enable investors to perform technical analysis and make data-driven decisions.
- Stay informed: Regular updates on AMGN's stock price keep investors informed about their investments.
What Should You Consider When Trading / Investing in AMGN?
Investing in AMGN involves certain risks and considerations that potential investors should keep in mind. The biotechnology sector can be highly volatile, and stock prices can react sharply to news and events.
- Risk tolerance: Investors should assess their risk tolerance before investing in biotech stocks due to their inherent volatility.
- Macro data: Economic indicators and healthcare policies can significantly affect AMGN's performance.
- Volatility warnings: Be prepared for price swings based on clinical trial results or regulatory news.
- Diversification: Consider diversifying your portfolio to mitigate risks associated with individual stocks.
- Long-term vs. short-term: Determine your investment strategy, whether you are looking for long-term growth or short-term gains.
What Can You Find on the Investvio AMGN Page?
- Live price updates: Get real-time pricing information for AMGN.
- Comprehensive charts: Analyze price trends over various time frames.
- Technical analysis: Access tools for in-depth technical analysis of AMGN's stock performance.
- Latest news: Stay updated on news and events that may impact AMGN.
- Earnings reports: Review quarterly earnings and projections for informed decision-making.
By utilizing the resources available on the Investvio AMGN page, investors can enhance their understanding of this essential biotech stock and make informed investment decisions. With the right information at their fingertips, investors can navigate the complexities of the biotechnology market with confidence.